In flammatory response in cardiovascular surgery

Inflammatory Response in Cardiovascular Surgery

Volumn , Issue , 2013, Pages 275-280

  Kaya, Kaan ^a  

^a Kavaklidere Umut Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956557552     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/9781447144298_32     Document Type: Chapter

References (22)

1. Ng CSH, Wan S, Yim APC, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest. 2002;121:1269-77.
2. Massoudy P, Zahler S, Becker BF, Braun SL, Barankay A, Meisner H. Evidence for inflammatory response of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest. 2001;119:31-6.
3. Cassey WF, Hauser GJ, Hannalah RS, Midgley FM, Khan W. Circulating endotoxin and tumour necrosis factor during paediatric cardiac surgery. Crit Care Med. 1992;20:1090-6.
4. Fortenberry JD, Bhardwaj V, Niemer P, et al. Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation. J Pediatr. 1996;128:670-8.
5. Gessler P, Pfenninger J, Pfammatter JP, Carrel T, Baenziger O, Dahinden C. Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg. 2003;126:718-25.
6. Jansen NJ, van Oeveren W, van der Brock L, et al. Inhibition by dexamethasone of the reperfusion phenomenon in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991;102:515-25.
7. Sun D, Xu C, Li J, Jiao X, Chen Y. Changes of inflammatory factors in patients with coronary artery disease during perioperation. Zhonghua Wai Ke Za Zhi. 2002;40:571-3.
8. Khabar KS, elBarbary MA, Khouqeer F, et al. Circulating endotoxins and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol. 1997;85:97-103.
9. Clermont G, Vergely C, de Girard C, Rochette L. Cellular injury associated with extracorporeal circulation. Ann Cardiol Angeiol. 2002;51:38-43.
10. Ulus AT, Aksoyek A, Ozkan M, Katircioglu SF, Basu S. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic Biol Med. 2003;34:911-7.
11. Kirklin JK, Westaby S, Blackstone EH, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845-57.
12. Bronicki RA, Backer CL, Baden HP, Mavroudis C, Crawford SE, Gren TP. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg. 2000;69:1490-5.
13. Matheve C. Clinical evidence of improved biocompatibility using heparin-coated surfaces. Perfusion. 1996;11:264-9.
14. Moen O, Hogasen K, Fosse E, et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1997;63:105-11.
15. Hamulu A, Discigil B, OZbaran M, et al. Complement consumption during cardiopulmonary bypass: comparison of Duraflo II heparin-coated and uncoated circuits in fully heparinized patients. Perfusion. 1996;11:333-7.
16. Gu YJ, de Vries AJ, Vos P, et al. Leukocyte depletion during cardiac operation. A new approach through the venous bypass circuit. Ann Thorac Surg. 1999;67:604-9.
17. Olivencia-Yurvatti AH, Ferrara CA, Tierney N, Wallace N, MAllet RT. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass. Perfusion. 2003;18 suppl 1:23-31.
18. Morioka K, Muraoka R, Chiba Y, et al. Leukocyte and platelet depletion with the blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;111:45-54.
19. Ascione R, Lloyd CT, Underwood MJ, et al. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg. 2000;69:1198-204.
20. Gu YJ, MAriani MA, van Oeveren W, et al. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg. 1998;65:420-4.
21. Brasil LA, Gomes WJ, Salomao R, et al. Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass. Ann Thorac Surg. 1998;66:56-9.
22. Wan S, LeClere JL, Vincent JL. Inflammatory response to cardiopulmonary bypass. Chest. 1997;112:676-92.